The majority of systemic anti-cancer therapies are not listed in this formulary as they are included in either the Lancashire and South Cumbria Cancer Alliance SACT protocols or the Cancer Drugs Fund list, produced by NHSE. |
Lanreotide |
Formulary
|
Pre-filled syringe 60mg, 90mg, 120mg (Depot) For orthostatic intolerance disorders - IFR needed. |
|
Octreotide |
Formulary
|
Injection 50 microgram/1mL, 1mg/5mL (multidose vial) For use in Bowel obstruction in palliative care, please see chapter 21. |
|
Octreotide |
Formulary
|
Depot injection 10mg, 20mg, 30mg For orthostatic intolerance disorders - IFR needed. |
|